StockData
Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc. (MTNB) stock

MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)

Close on Nov 18, 2026Market cap $13.37MP/E –Yield –

Matinas BioPharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Matinas BioPharma's enterprise value was $5.20M on Nov 11, 2026, against $60.95M a year earlier. Over the last 5 years it ranged from $5.20M to $3.22B, with a median of $518.06M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.20M-88.8%
2025Dec 31, 2025$46.43M+65.1%
2024Dec 31, 2024$28.12M-95.9%
2023Dec 29, 2023$686.34M-56.9%
2022Dec 30, 2022$1.59B-50.6%
2021Dec 31, 2021$3.22B-19.4%
2020Dec 31, 2020$4.00B-27.9%
2019Dec 31, 2019$5.54B+540.3%
2018Dec 31, 2018$865.27M-46.2%
2017Dec 29, 2017$1.61B+32.9%
2016Dec 30, 2016$1.21B–

More Matinas BioPharma figures

See a number that looks wrong?